← Gene index
NAT2
HGNC ↗1 article(s) in the watch · Pharmacogenomics
NAT2 determines acetylator status (slow/fast), modulating the metabolism of drugs such as isoniazid, sulfasalazine and some amines. Slow acetylators are more prone to certain adverse effects.
PharmacogenomicsEmerging
Drugs involved: isoniazid, hydralazine, sulfonamides
Recommendation: Emerging evidence